Our cells exist in a constant state of chemical balance. A key aspect of this is the “redox state”—the balance between oxidizing and reducing molecules. When this balance is disrupted by an excess of reactive oxygen species, it leads to oxidative stress, a condition implicated in everything from aging to cancer. For years, scientists have studied how proteins are modified in response to this stress, with disulfide bonds being the classic example of a redox-sensitive switch.

The recent discovery of nitrogen-oxygen-sulfur (NOS) linkages in proteins adds a major new player to the field of redox biology. These unusual covalent bonds, found between residues like arginine-cysteine and glycine-cysteine, are not merely structural supports. Evidence suggests they are dynamic, reversible cross-links that act as sophisticated allosteric redox switches. This means they form or break in response to changes in the cellular redox environment, and in doing so, they can modulate a protein’s activity from a distance.

By forming an NOS bridge, a protein can subtly alter its 3D shape, which in turn can change the conformation of its active site or affect its ability to bind to other proteins. This provides a mechanism for fine-tuning cellular processes in response to oxidative stress. Understanding how these switches work has profound implications. In disease, these switches might be stuck in the “on” or “off” position. In protein engineering, we could harness this mechanism to design novel biosensors that report on a cell’s redox state, or create therapeutics that are only activated under the specific oxidative conditions found in a tumor.